Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1)

Pharmacogenetics and Genomics

Volumn 15, Issue 4, 2005, Pages 201-209

  Fujita, Tomoe ^a   Brown, Chaline ^b   Carlson, Elaine J ^b   Taylor, Travis ^b   De La Cruz, Melanie ^b   Johns, Susan J ^b   Stryke, Doug ^b   Kawamoto, Michiko ^b   Fujita, Kazumi ^a   Castro, Richard ^b   Chen, Chung Wen ^b   Lin, Emil T ^b   Brett, Claire M ^c   Gonzalez Burchard, Esteban ^b   Ferrin, Thomas E ^b   Huang, Conrad C ^d   Leabman, Maya K ^b   Giacomini, Kathleen M ^b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE

Author keywords

Organic anion transporter; Pharmacogenetics; Renal elimination

Indexed keywords

4 AMINOHIPPURIC ACID; ABC TRANSPORTER; ACYLTRANSFERASE; ADEFOVIR; ANTIVIRUS AGENT; CARRIER PROTEIN; CHOLINESTERASE; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; DNA; DODECYL SULFATE SODIUM; GENOMIC DNA; METHOTREXATE; MYCOTOXIN; OCHRATOXIN; ORGANIC ANION TRANSPORTER; PROBENECID; THIOPURINE METHYLTRANSFERASE; TOXIN; XENOBIOTIC AGENT;

ADULT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; DRUG ELIMINATION; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENETIC SCREENING; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; INTERNALIZATION; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PARAMETER; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN VARIANT; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; TRANSPORT KINETICS; XENOPUS LAEVIS;

XENOPUS LAEVIS;

EID: 20244389716     PISSN: 17446872     EISSN: None     Source Type: Journal    
DOI: 10.1097/01213011-200504000-00003     Document Type: Article

References (23)

1. Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999; 286:487-491.
2. Leabman MK, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, et al. Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. Pharmacogenetics 2002; 12:395-405.
3. Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, de la Cruz M, et al. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci USA 2003; 100:5896-5901.
4. Osato DH, Huang CC, Kawamoto M, Johns SJ, Stryke D, Wang J, et al. Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENTI. Pharmacogenetics 2003; 13:297-301.
5. Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D, et al. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci USA 2003; 100: 5902-5907.
6. Lockhart AC, Tirona RG, Kim RB. Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy. Mol Cancer Ther 2003; 2:685-698.
7. Schwab M, Eichelbaum M, Fromm MF. Genetic polymorphisms of the human MDR1 drug transporter. Annu Rev Pharmacol Toxicol 2003; 43: 285-307.
8. Lu R, Chan BS, Schuster VL. Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. Am J Physiol 1999; 276:F295-F303.
9. Race JE, Grassl SM, Williams WJ, Holtzman EJ. Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Commun 1999; 255: 508-514.
10. Reid G, Wolff NA, Dautzenberg FM, Burckhardt G. Cloning of a human renal p-aminohippurate transporter hROAT1. Kidney Blood Press Res 1998; 21: 233-237.
11. Hosoyamada M, Sekine T, Kanai Y, Endou H. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol 1999; 276:F122-F128.
12. Cihlar T, Lin DC, Pritchard JB, Fuller MD, Mendel DB, Sweet DH. The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Mol Pharmacol 1999; 56:570-580.
13. Leabman MK, Giacomini KM. Estimating the contribution of genes and environment to variation in renal drug clearance. Pharmacogenetics 2003; 13:581-584.
14. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 1989; 123:585-595.
15. Hartl DL, Clark AG. Principles of population genetics. 3rd Edition. Sunderland, MA: Sinauer Associates, Inc.; 1997.
16. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
17. Kimura H, Takeda M, Narikawa S, Enomoto A, Ichida K, Endou H. Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J Pharmacol Exp Ther 2002; 301: 293-298.
18. Sun W, Wu RR, van Poelje PD, Erion MD. Isolation of a family of organic anion transporters from human liver and kidney. Biochem Biophys Res Commun 2001; 283:417-422.
19. Enomoto A, Takeda M, Top A, Sekine T, Cha SH, Khamdang S, et al. Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol 2002; 13: 1711-1720.
20. Feng B, Dresser MJ, Shu Y, Johns SJ, Giacomini KM. Arginine 454 and lysine 370 are essential for the anion specificity of the organic anion transporter, rOAT3. Biochemistry 2001; 40:5511-5520.
21. Wolff NA, Grunwald B, Friedrich B, Lang F, Godehardt S, Burckhardt G. Cationic amino acids involved in dicarboxylate binding of the flounder renal organic anion transporter. J Am Soc Nephrol 2001; 12:2012-2018.
22. Product Information: Hepsera(TM), Adefovir dipivoxil tablets. Gilead Sciences, Inc., Foster City, CA, Issued 09/2002 (reviewed 09/2002).
23. Cihlar T, Ho ES, Lin DC, Mulato AS. Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Nucleosides Nucleotides Nucleic Acids 2001; 20:641-648.